Literature DB >> 16629699

The association of the PON1 Q192R polymorphism with complications and outcomes of pregnancy: findings from the British Women's Heart and Health cohort study.

Debbie A Lawlor1, Tom R Gaunt, Lesley J Hinks, George Davey Smith, Nick Timpson, Ian N M Day, Shah Ebrahim.   

Abstract

It has been hypothesised that paraoxonase genes would be related to adverse pregnancy outcomes, via a maternal or fetal effect on placental hypoperfusion and thrombosis. To date only two studies have assessed this possibility. In this study we assessed the associations of the PON1 Q192R polymorphism with self-report of having pregnancy-induced hypertension, gestational hyperglycaemia and a preterm offspring birth. The associations were assessed in 3266 white women who were randomly selected from 23 British towns. There was no association between PON1 Q192R and either self-report of pregnancy-induced hypertension or gestational hyperglycaemia but the prevalence of reporting having a preterm birth increased with each R allele: per allele odds ratio 1.20 [95% confidence interval (CI) 1.03, 1.41]. When our results were pooled with the one previous study of the association of this polymorphism with preterm birth, the pooled per allele odds ratio was 1.19 [95% CI 1.02, 1.39]. Our findings provide some further evidence to suggest that PON1 Q192R is associated with preterm birth; they invite further investigation of both maternal and fetal genotype for PON1 Q192R in relation to preterm birth.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16629699     DOI: 10.1111/j.1365-3016.2006.00716.x

Source DB:  PubMed          Journal:  Paediatr Perinat Epidemiol        ISSN: 0269-5022            Impact factor:   3.980


  8 in total

1.  Paraoxonase 1 (PON1) status and substrate hydrolysis.

Authors:  Rebecca J Richter; Gail P Jarvik; Clement E Furlong
Journal:  Toxicol Appl Pharmacol       Date:  2008-11-13       Impact factor: 4.219

2.  Mapping haplotype-haplotype interactions with adaptive LASSO.

Authors:  Ming Li; Roberto Romero; Wenjiang J Fu; Yuehua Cui
Journal:  BMC Genet       Date:  2010-08-27       Impact factor: 2.797

3.  Determination of paraoxonase 1 status without the use of toxic organophosphate substrates.

Authors:  Rebecca J Richter; Gail P Jarvik; Clement E Furlong
Journal:  Circ Cardiovasc Genet       Date:  2008-12

4.  Association of organophosphate pesticide exposure and paraoxonase with birth outcome in Mexican-American women.

Authors:  Kim G Harley; Karen Huen; Raul Aguilar Schall; Nina T Holland; Asa Bradman; Dana Boyd Barr; Brenda Eskenazi
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

Review 5.  Pathogenesis of preeclampsia: the genetic component.

Authors:  Francisco J Valenzuela; Alejandra Pérez-Sepúlveda; María J Torres; Paula Correa; Gabriela M Repetto; Sebastián E Illanes
Journal:  J Pregnancy       Date:  2011-12-01

6.  Developmental changes in PON1 enzyme activity in young children and effects of PON1 polymorphisms.

Authors:  Karen Huen; Kim Harley; Jordan Brooks; Alan Hubbard; Asa Bradman; Brenda Eskenazi; Nina Holland
Journal:  Environ Health Perspect       Date:  2009-06-09       Impact factor: 9.031

7.  Validation of PON1 enzyme activity assays for longitudinal studies.

Authors:  Karen Huen; Rebecca Richter; Clement Furlong; Brenda Eskenazi; Nina Holland
Journal:  Clin Chim Acta       Date:  2008-12-24       Impact factor: 3.786

8.  Evaluation of Maternal Serum 25-Hydroxyvitamin D, Paraoxonase 1 Levels, and Neutrophil-to-Lymphocyte Ratio in Spontaneous Preterm Birth.

Authors:  Ozlem Bozoklu Akkar; Enver Sancakdar; Savas Karakus; Caglar Yildiz; Ismail Akkar; Murat Arslan; Irfan Oguz Sahin; Ayse Gonca Imir Yenicesu; Ali Cetin
Journal:  Med Sci Monit       Date:  2016-04-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.